Analysis at day 28 showed responding tumors with significant CD4+ and CD8+ infiltration (> 200 cells/mm2) either peripherally or throughout the tumor mass, correlating with MRMI enhancement patterns. This evidence concerns the gene CD8A and neoplasm.